Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 851487, 8 pages
http://dx.doi.org/10.1155/2012/851487
Clinical Study

Acute Hyperglycemia Does Not Impair Microvascular Reactivity and Endothelial Function during Hyperinsulinemic Isoglycemic and Hyperglycemic Clamp in Type 1 Diabetic Patients

13rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 12800 Prague, Czech Republic
2Department of Hematology, 1st Faculty of Medicine, Charles University, U Nemocnice 2, 12800 Prague, Czech Republic

Received 13 July 2011; Accepted 22 September 2011

Academic Editor: Bernard Portha

Copyright © 2012 Eva Horová et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, “10-Year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Google Scholar
  3. UK Prospective Diabetes Study Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Google Scholar
  4. D. M. Nathan, P. A. Cleary, J. Y. C. Backlund et al., “Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes,” The New England Journal of Medicine, vol. 353, no. 25, pp. 2643–2653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Muggeo, G. Zoppini, E. Bonora et al., “Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study,” Diabetes Care, vol. 23, no. 1, pp. 45–50, 2000. View at Google Scholar · View at Scopus
  6. M. Muggeo, G. Verlato, E. Bonora, G. Zoppini, M. Corbellini, and R. De Marco, “Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the verona diabetes study,” Circulation, vol. 96, no. 6, pp. 1750–1754, 1997. View at Google Scholar · View at Scopus
  7. J. A. Gimeno-Orna, F. J. Castro-Alonso, B. Boned-Juliani, and L. M. Lou-Arnal, “Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients,” Journal of Diabetes and Its Complications, vol. 17, no. 2, pp. 78–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Takao, T. Ide, H. Yanagisawa, M. Kikuchi, S. Kawazu, and Y. Matsuyama, “The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up,” Diabetes Research and Clinical Practice, vol. 89, no. 3, pp. 296–302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Bragd, U. Adamson, L. B. Bäcklund, P. E. Lins, E. Moberg, and P. Oskarsson, “Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type1 diabetes over a decade?” Diabetes and Metabolism, vol. 34, no. 6, pp. 612–616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin, “The effect of glucose variability on the risk of microvascular complications in type 1 diabetes,” Diabetes Care, vol. 29, no. 7, pp. 1486–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Siegelaar, E. S. Kilpatrick, A. S. Rigby, S. L. Atkin, J. B. L. Hoekstra, and J. H. Devries, “Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT,” Diabetologia, vol. 52, no. 10, pp. 2229–2232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Brownlee and I. B. Hirsch, “Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1707–1708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, and A. Ceriello, “Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation,” Diabetes, vol. 52, no. 11, pp. 2795–2804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Risso, F. Mercuri, L. Quagliaro, G. Damante, and A. Ceriello, “Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture,” American Journal of Physiology—Endocrinology and Metabolism, vol. 281, no. 5, pp. E924–E930, 2001. View at Google Scholar · View at Scopus
  16. I. M. E. Wentholt, W. Kulik, R. P. J. Michels, J. B. L. Hoekstra, and J. H. DeVries, “Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes,” Diabetologia, vol. 51, no. 1, pp. 183–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ceriello, K. Esposito, L. Piconi et al., “Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients,” Diabetes, vol. 57, no. 5, pp. 1349–1354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Monnier, E. Mas, C. Ginet et al., “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1681–1687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Rask-Madsen and G. L. King, “Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 1, pp. 46–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. J. Wassink, J. K. Olijhoek, and F. L. J. Visseren, “The metabolic syndrome: metabolic changes with vascular consequences,” European Journal of Clinical Investigation, vol. 37, no. 1, pp. 8–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. G. Joshua, Q. Zhang, J. C. Falcone, A. P. Bratcher, W. E. Rodriguez, and S. C. Tyagi, “Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide,” Journal of Cellular Biochemistry, vol. 96, no. 6, pp. 1149–1156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. H. N. Oomen, G. D. Kant, R. P. F. Dullaart, W. D. Reitsma, and A. J. Smit, “Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction,” Microvascular Research, vol. 63, no. 1, pp. 1–9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. V. Chittari, P. McTernan, N. Bawazeer et al., “Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes,” Diabetic Medicine, vol. 28, no. 4, pp. 450–454, 2011. View at Google Scholar
  24. P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty, “Insulin as an anti-inflammatory and antiatherogenic modulator,” Journal of the American College of Cardiology, vol. 53, supplement 5, pp. S14–S20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kuboki, Z. Y. Jiang, N. Takahara et al., “Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo—a specific vascular action of insulin,” Circulation, vol. 101, no. 6, pp. 676–681, 2000. View at Google Scholar · View at Scopus
  26. L. Monnier, C. Colette, E. Mas et al., “Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy,” Diabetologia, vol. 53, no. 3, pp. 562–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, no. 3, pp. E214–E223, 1979. View at Google Scholar · View at Scopus
  28. G. Šindelka, J. Škrha, M. Prázný, and T. Haas, “Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action,” Physiological Research, vol. 51, no. 1, pp. 85–91, 2002. View at Google Scholar · View at Scopus
  29. K. Yagi, “A simple fluorometric assay for lipoperoxide in blood plasma,” Biochemical Medicine, vol. 15, no. 2, pp. 212–216, 1976. View at Google Scholar · View at Scopus
  30. A. Clauss, “A rapid physiological coagulation method for the determination of plasma fibrinogen,” Lancet, vol. 2, p. 501, 1951. View at Google Scholar
  31. C. Freccero, F. Holmlund, S. Bornmyr et al., “Laser Doppler perfusion monitoring of skin blood flow at different depths in finger and arm upon local heating,” Microvascular Research, vol. 66, no. 3, pp. 183–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. B. Meigs, C. J. O'Donnell, G. H. Tofler et al., “Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study,” Diabetes, vol. 55, no. 2, pp. 530–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Škrha, M. Prázný, T. Haas, J. Kvasnička, and B. Kalvodová, “Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients,” Journal of Diabetes and Its Complications, vol. 15, no. 5, pp. 234–240, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Škrha, “Diabetes and vascular disease: from pathogenesis to treatment. Are vascular effects of hypoglycemic and hypolipidemic drugs independent of their metabolic effects?” Diabetes and Metabolic Syndrome, vol. 1, no. 1, pp. 61–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Kotzailias, M. Graninger, M. Knechtelsdorfer, and B. Jilma, “Acute effects of hyperglycaemia on plasma concentration of soluble P-selectin and von Willebrand Factor in healthy volunteers -a prospective randomised double blind controlled study,” Thrombosis Research, vol. 123, no. 3, pp. 452–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Undas, I. Wiek, E. Stêpień, K. Zmudka, and W. Tracz, “Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome,” Diabetes Care, vol. 31, no. 8, pp. 1590–1595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. V. R. Vaidyula, G. Boden, and A. K. Rao, “Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects,” Platelets, vol. 17, no. 8, pp. 577–585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. V. R. Vaidyula, A. K. Rao, M. Mozzoli, C. Homko, P. Cheung, and G. Boden, “Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand,” Diabetes, vol. 55, no. 1, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. D. Blann, S. K. Nadar, and G. Y. H. Lip, “The adhesion molecule P-selectin and cardiovascular disease,” European Heart Journal, vol. 24, no. 24, pp. 2166–2179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Weyer, C. Bogardus, D. M. Mott, and R. E. Pratley, “The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus,” Journal of Clinical Investigation, vol. 104, no. 6, pp. 787–794, 1999. View at Google Scholar · View at Scopus
  42. M. Y. Donath and P. A. Halban, “Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications,” Diabetologia, vol. 47, no. 3, pp. 581–589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Geddes, J. E. Schopman, N. N. Zammitt, and B. M. Frier, “Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes,” Diabetic Medicine, vol. 25, no. 4, pp. 501–504, 2008. View at Publisher · View at Google Scholar · View at Scopus